For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Further details of Middlemore death released
This item is over 2 years old; some content may no longer be current
+Undoctored
Further details of Middlemore death released
Wednesday 6 October 2021, 04:18 PM

The Ministry is providing further details of the death reported earlier today in Middlemore hospital linked to COVID-19.
The man in his 50s had underlying health conditions and was a confirmed case of COVID-19.
The patient spent a total of 40 days in ICU.
He was admitted to Middlemore hospital on 27 August from home.
His family is being supported by their church and community.
‘Our thoughts are with his whānau at this deeply sad time’, says Director of Public Health Dr Caroline McElnay.